Canagliflozin impairs blood reperfusion of ischaemic lower limb partially by inhibiting the retention and paracrine function of bone marrow derived mesenchymal stem cells
Background: Canagliflozin (CANA) administration increases the risk of lower limb amputation in the clinic. The present study aimed to investigate whether and how CANA interferes with the intracellular physiological processes of bone marrow derived mesenchymal stem cells (BM-MSCs) and its contributio...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2020-02-01
|
| 叢編: | EBioMedicine |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2352396420300128 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|